SYNGENE.NS
Syngene International Ltd
Price:  
635.25 
INR
Volume:  
571,710
India | Life Sciences Tools & Services

SYNGENE.NS WACC - Weighted Average Cost of Capital

The WACC of Syngene International Ltd (SYNGENE.NS) is 13.0%.

The Cost of Equity of Syngene International Ltd (SYNGENE.NS) is 13.15%.
The Cost of Debt of Syngene International Ltd (SYNGENE.NS) is 5.75%.

RangeSelected
Cost of equity11.6% - 14.7%13.15%
Tax rate18.1% - 19.7%18.9%
Cost of debt4.0% - 7.5%5.75%
WACC11.5% - 14.5%13.0%
WACC

SYNGENE.NS WACC calculation

CategoryLowHigh
Long-term bond rate6.9%7.4%
Equity market risk premium8.3%9.3%
Adjusted beta0.570.73
Additional risk adjustments0.0%0.5%
Cost of equity11.6%14.7%
Tax rate18.1%19.7%
Debt/Equity ratio
0.020.02
Cost of debt4.0%7.5%
After-tax WACC11.5%14.5%
Selected WACC13.0%

SYNGENE.NS's CAPM model and how its cost of Equity is calculated

The Cost of Equity reflects the return a company needs to deliver to shareholders to justify the risk of investing in its shares. It’s computed using the Capital Asset Pricing Model (CAPM), which blends the risk-free rate, the stock’s beta, and the market risk premium.

This method evaluates the stock’s risk compared to a safe investment and the market’s overall volatility.

Here’s how we figure out the cost of equity for SYNGENE.NS:

cost_of_equity (13.15%) = risk_free_rate (7.15%) + equity_risk_premium (8.80%) * adjusted_beta (0.57) + risk_adjustments (0.25%)

We include the risk adjustments, which range from 0% to 1%, to keep our WACC conservatives, especially for companies traded in developing markets.